Background: The CKD population is becoming increasingly elderly with multiple comorbidities. For this reason, accurate predictive information related to the progression into ESRD, mortality, and functional decline is critical to allow for optimal shared decision making (SDM). Summary: This review will assess the current literature on the methodologies for the estimation of prognosis and prognostic tools developed for CKD. A practical clinical approach is discussed that involves the estimation of prognosis and integration of prognosis into SDM. Key Message: There are validated, easy-to-use prognostic tools that help clinicians engage in effective shared decision making with their CKD patients and family.

Keywords:
Prognosis, Mortality, CKD, ESRD, Dialysis, Shared decision making, Quality of life, Palliative care, Supportive care, Elderly
1.
Renal Physicians Association: Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis, ed 2. Rockville, Maryland, 2010.
2.
Glare PA, Sinclair CT: Palliative medicine review: prognostication. J Palliat Med 2008;11:84-103.
3.
Davison SN: End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010;5:195-204.
4.
US Renal Data System: USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases, 2012.
5.
Kurella M, Covinsky KE, Collins AJ, et al: Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 2007;146:177-183.
6.
Jassal SV, Chiu E, Hadunewich M: Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 2009;361:1612-1613.
7.
Schell JO, Da Silva-Gane M, Germain MJ: Recent insights into life expectancy with and without dialysis. Curr Opin Nephrol Hypertens 2013;22:185-192.
8.
O'Connor NR, Kumar P: Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med 2012;15:228-235.
9.
Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007;22:1955-1962.
10.
Carson RC, Juszczak M, Davenport A, Burns A: Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 2009;4:1611-1619.
11.
Da Silva-Gane M, Wellsted D, Greenshields H, Norton S, Chandna SM, Farrington K: Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol 2012;7:2002-2009.
12.
Vandecasteele SJ, Kurella Tamura M: A patient-centered vision of care for ESRD: dialysis as a bridging treatment or as a final destination? J Am Soc Nephrol 2014;25:1647-1651.
13.
Churchill DN, Jassal SV: Dialysis: destination or journey. J Am Soc Nephrol 2014;25:1609-1611.
14.
Bowling CB, O'Hare AM: Managing older adults with CKD: individualized versus disease based approaches. Am J Kidney Dis 2012;59:293-302.
15.
Tamura MK, Tan JC, O'Hare AM: Optimizing renal replacement therapy in older adults: a framework for making individualized decisions. Kidney Int 2012;82:261-269.
16.
Grubbs V, Moss AH, Cohen LM, Fisher MJ, Germain MJ, Jassal SV, Perl J, Weiner DE, Mehrotra R: A Palliative Approach to Dialysis Care: A Patient-Centered Transition to the End of Life. Clin J Am Soc Nephrol 2014, DOI: 10.2215/CJN.00650114.
17.
Hendriksen JM, Geersing GJ, Moons KG, de Groot JA: Diagnostic and prognostic prediction models. J Thromb Haemost 2013;11(suppl 1):129-141.
18.
Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG: Prognosis and prognostic research: what, why, and how? BMJ 2009;338:B375.
19.
Justice AC, Covinsky KE, Berlin JA: Assessing the generalizability of prognostic information. Ann Intern Med 1999;130:515-524.
20.
Rigatto C, Sood MM, Tangri N: Risk prediction in chronic kidney disease: pitfalls and caveats. Curr Opin Nephrol Hypertens 2012;21:612-618.
21.
Cochrane Prognosis Methods Group: Scope of Our Work; Available from: http://prognosismethods.cochrane.org/scope-our-work (cited May 25, 2014).
22.
Royston P, Moons KG, Altman DG, Vergouwe Y: Prognosis and prognostic research: developing a prognostic model. BMJ 2009;338:B604.
23.
Moss AH, Ganjoo J, Sharma S, Gansor J, Senft S, Weaner B, et al: Utility of the ‘surprise' question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol 2008;3:1379-1384.
24.
Chow E, Harth T, Hruby G, Finkelstein J, Wu J, Danjoux C: How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol) 2001;13:209-218.
25.
Tangri N, Kitsios GD, Inker LA, Griffith J, Naimark DM, et al: Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med 2013;158:596-603.
26.
Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al: A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011;305:1553-1559.
27.
Landray MJ, Emberson JR, Blackwell L, Dasgupta T, Zakeri R, Morgan MD, et al: Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis 2010;56:1082-1094.
28.
Levin A, Rigatto C, Brendan B: Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT). BMC Nephrol 2013;14:121.
29.
Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, et al: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007;2:89-99.
30.
Couchoud C, Labeeuw M, Moranne O, Allot V, Esnault V, Frimat L, et al: A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009;24:1553-1561.
31.
Wong SP, Kreuter W, O'Hare AM: Healthcare intensity at initiation of chronic dialysis among older adults. J Am Soc Nephrol 2014;25:143-149.
32.
Cheung KL, Montez-Rath ME, Chertow GM, Winkelmayer WC, Periyakoil VS, Kurella Tamura M: Prognostic stratification in older adults commencing dialysis. J Gerontol A Biol Sci Med Sci 2014;69:1033-1039.
33.
Quinn RR, Laupacis A, Hux JE, Oliver MJ, Austin PC: Predicting the risk of 1-year mortality in incident dialysis patients: accounting for case-mix severity in studies using administrative data. Med Care 2011;49:257-266.
34.
Usvyat LA, Kooman JP, van der Sande FM, Wang Y, Maddux FW, Levin NW, et al: Dynamics of hospitalizations in hemodialysis patients: results from a large US provider. Nephrol Dial Transplant 2014;29:442-448.
35.
Cohen LM, Ruthazer R, Moss AH, Germain MJ: Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol 2010;5:72-79.
36.
Pang WF, Kwan BC, Chow KM, Leung CB, Li PK, Szeto CC: Predicting 12-month mortality for peritoneal dialysis patients using the ‘surprise' question. Perit Dial Int 2013;33:60-66.
37.
Holley JL: Advance care planning in CKD/ESRD: an evolving process. Clin J Am Soc Nephrol 2012;7:1033-1038.
38.
Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K: Nutritional predictors of early mortality in incident hemodialysis patients. Int Urol Nephrol 2014;46:129-140. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23703546.
39.
Davison SN, Jhangri GS, Holley JL, Moss AH: Nephrologists' reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol 2006;1:1256-1262.
40.
Davison SN: Facilitating advance care planning for patients with end-stage renal disease: the patient perspective. Clin J Am Soc Nephrol 2006;1:1023-1028.
41.
Schell JO, Green JA, Tulsky JA, Arnold RM: Communication skills training for dialysis decision-making and end-of-life care in nephrology. Clin J Am Soc Nephrol 2013;8:675-680.
42.
Schell JO, Patel UD, Steinhauser KE, Ammarell N, Tulsky JA: Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study. Am J Kidney Dis 2012;59:495-503.
43.
Quill TE, Holloway R: Time-limited trials near the end of life. JAMA 2011;306:1483-1484.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.